Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NOXA1 Antikörper (AA 38-434)

Der Kaninchen Polyklonal anti-NOXA1 Antikörper wird verwendet zum Nachweis von NOXA1 in Proben von Human. Er wurde validiert für WB und ELISA.
Produktnummer ABIN7874508
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für NOXA1 Antikörper (AA 38-434) (ABIN7874508)

Target

Alle NOXA1 Antikörper anzeigen
NOXA1 (NADPH Oxidase Activator 1 (NOXA1))

Reaktivität

  • 25
  • 18
  • 17
Human

Wirt

  • 53
  • 2
Kaninchen

Klonalität

  • 55
Polyklonal

Konjugat

  • 18
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser NOXA1 Antikörper ist unkonjugiert

Applikation

  • 51
  • 26
  • 26
  • 20
  • 6
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 15
    • 15
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 38-434

    Verwendungszweck

    NOXA1 Antibody / NADPH oxidase activator 1

    Aufreinigung

    Immunogen affinity purified

    Immunogen

    E.coli-derived human NOXA1 recombinant protein (Position: A38-Q434) was used as the immunogen for the NOXA1 antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the NOXA1 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    After reconstitution, the NOXA1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    NOXA1 (NADPH Oxidase Activator 1 (NOXA1))

    Andere Bezeichnung

    NOXA1

    Hintergrund

    NOXA1 antibody detects NADPH oxidase activator 1, a cytoplasmic adaptor protein encoded by the NOXA1 gene located on chromosome 9q34.3. NOXA1 is an essential activator of the NADPH oxidase (NOX) enzyme family, which catalyzes the production of reactive oxygen species (ROS) in various cell types. It is highly expressed in colon, kidney, brain, and vascular smooth muscle cells, where it modulates redox signaling, host defense, and cell proliferation. NOXA1 belongs to the NOXO/NOXA family of cytosolic regulatory proteins that assemble with membrane-bound catalytic subunits to activate superoxide generation.

    NOXA1 functions as an organizer and activator of NOX1 and NOX3 oxidase complexes. It forms part of a multi-protein complex that includes NOX1, NOXO1, p22phox, and Rac1/2, facilitating electron transfer from NADPH to oxygen. Through this mechanism, NOXA1 regulates ROS-dependent signaling pathways that influence gene expression, cytoskeletal dynamics, and cellular adaptation to stress. Its activation is stimulated by inflammatory cytokines, mechanical stress, and growth factors, integrating redox regulation with cell signaling networks.

    Structurally, NOXA1 contains an N-terminal tetratricopeptide repeat (TPR) domain that interacts with NOXO1, a central proline-rich region for SH3 domain binding, and a C-terminal PB1 domain that mediates heterodimerization with NOX enzymes. These modular features allow NOXA1 to coordinate assembly of the active oxidase complex at the plasma membrane or endosomal compartments. NOXA1 is classified within the NADPH oxidase activator family, alongside NOXA2 (p67phox) and NOXO1, which share conserved interaction motifs.

    Functionally, NOXA1 contributes to host defense and redox signaling rather than direct microbial killing, as its activity produces low levels of ROS for signaling purposes. It regulates processes such as vascular tone, cell migration, and epithelial barrier function. NOXA1 also modulates oxidative stress responses and participates in MAPK and NF-kappaB signaling cascades triggered by ROS intermediates. Co-localization studies show that NOXA1 associates with NOX1 at the plasma membrane and with cytoskeletal scaffolds in migrating cells.

    Dysregulation of NOXA1 is associated with hypertension, inflammatory bowel disease, and cancer. Overexpression can enhance oxidative stress and contribute to tumor progression, while deficiency impairs epithelial defense and wound repair. Pathway involvement includes ROS-mediated signaling, PI3K-AKT, and TGF-beta pathways. Developmentally, NOXA1 expression increases during epithelial differentiation and vascular remodeling, reflecting its adaptive redox control functions.

    The NOXA1 antibody from NSJ Bioreagents is a useful reagent for investigating ROS signaling, NOX complex activation, and redox-regulated cellular processes.

    UniProt

    Q86UR1
Sie sind hier:
Chat with us!